| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C0033522> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C0035435> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35383121_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands l.boekel@reade.nl.\', \'Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands.\', \'Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.\', \'Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands.\', \'Department of Pediatric Immunology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.\', \'Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.\', \'Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.\', \'Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, The Netherlands.\', \'Department of Epidemiology & Data Science, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Atiqi_Sadaf> <https://research.tib.eu/covid-19/entity/Bakhlakh_Siham> <https://research.tib.eu/covid-19/entity/Besten_Ya%C3%ABlle_R> <https://research.tib.eu/covid-19/entity/Boekel_Laura> <https://research.tib.eu/covid-19/entity/Boers_Maarten> <https://research.tib.eu/covid-19/entity/Cristianawati_Olvi> <https://research.tib.eu/covid-19/entity/Crooijmans_Juliette_J> <https://research.tib.eu/covid-19/entity/Dijkshoorn_Bas> <https://research.tib.eu/covid-19/entity/Eftimov_Filip> <https://research.tib.eu/covid-19/entity/Gerritsen_Martijn> <https://research.tib.eu/covid-19/entity/Hooijberg_Femke> <https://research.tib.eu/covid-19/entity/Keijser_Jim> <https://research.tib.eu/covid-19/entity/Keijzer_Sofie> <https://research.tib.eu/covid-19/entity/Krieckaert_C> <https://research.tib.eu/covid-19/entity/Kuijpers_Taco_W> <https://research.tib.eu/covid-19/entity/Kummer_Laura_Y> <https://research.tib.eu/covid-19/entity/Leeuw_Maureen> <https://research.tib.eu/covid-19/entity/Lems_Willem> <https://research.tib.eu/covid-19/entity/Loeff_Floris_C> <https://research.tib.eu/covid-19/entity/Nurmohamed_Michael_T> <https://research.tib.eu/covid-19/entity/Rispens_Theo> <https://research.tib.eu/covid-19/entity/Stalman_Eileen_W> <https://research.tib.eu/covid-19/entity/Steenhuis_Maurice> <https://research.tib.eu/covid-19/entity/Tas_Sander_W> <https://research.tib.eu/covid-19/entity/Vogelzang_Erik_H> <https://research.tib.eu/covid-19/entity/Voskuyl_Alexandre> <https://research.tib.eu/covid-19/entity/Wieske_Luuk> <https://research.tib.eu/covid-19/entity/Wijbrandts_Carla_A> <https://research.tib.eu/covid-19/entity/Wolbink_Gertjan> <https://research.tib.eu/covid-19/entity/van_Dam_Pj_Koos> <https://research.tib.eu/covid-19/entity/van_Ham_S_Marieke> <https://research.tib.eu/covid-19/entity/van_Vollenhoven_Ronald_F> <https://research.tib.eu/covid-19/entity/van_der_Horst-Bruinsma_Irene_E>
?:doi	e00203510.1136/rmdopen-2021-002035
?:doi	<https://research.tib.eu/covid-19/entity/e00203510.1136/rmdopen-2021-002035>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	RMD open
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35383121>
?:pmid	<https://research.tib.eu/covid-19/entity/35383121>
?:pmid	35383121
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.169
?:rankingScore_hIndex	13
?:title	Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands l.boekel@reade.nl.\', \'Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Amsterdam, The Netherlands.\', \'Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.\', \'Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University medical center, Amsterdam, The Netherlands.\', \'Department of Pediatric Immunology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.\', \'Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.\', \'Department of Neurology and Neurophysiology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.\', \'Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, The Netherlands.\', \'Department of Epidemiology & Data Science, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.\']

?:citedBy

-1

?:creator

?:doi

e00203510.1136/rmdopen-2021-002035

?:doi

<https://research.tib.eu/covid-19/entity/e00203510.1136/rmdopen-2021-002035>

?:hasPublicationType

<https://research.tib.eu/covid-19/entity/Journal_Article>

?:journal

RMD open

is ?:pmid of

<https://research.tib.eu/covid-19/entity/35383121>

?:pmid

<https://research.tib.eu/covid-19/entity/35383121>

?:pmid

35383121

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

2.169

?:rankingScore_hIndex

?:title

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.

?:type

?:year

2022

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35383121>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35383121>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata